迪安诊断 (300244)

DIAN DIAGNOSTICS GROUP CO.,LTD.

ASZ

Tags

AI HealthcareAI AgentsContract Research Organization (CXO)DeepSeekQFII Heavy PositionsImmunotherapyCold ChainMedical ServicesPharmaceuticals and HealthcareHealthGuozheng Growth IndexGuozheng Services IndexGene ConceptMultimodal AICCTV 50 IndexInfant and Child ConceptSmall Cap GrowthLow-Profit StocksHepatitis ConceptAssisted ReproductionAlibaba ConceptChiNext Small CapChiNext IndexChiNext Blue ChipChiNext HealthcareShenzhen ConnectSZSE 300 IndexSZSE Value IndexTech 100 IndexPharma & BiotechSZSE Medicine Equal Weight IndexSina 100 IndexShenzhen A-Share Pharmaceutical IndexChiNext Equal Weight IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexEmerging Technology 100 IndexSZSE 700 IndexSZSE Emerging Industries IndexSSE 700 Growth IndexSHS Technology 100 IndexZhongchuang Growth IndexSZSE 1000 IndexHangzhou Bay Area IndexSZSE 300 Return IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnCNI 1000 IndexCR Foundation IndexCSI Medical IndexCS Precision Medicine IndexZhongchuang Value IndexChiNext Value IndexCSI 500 Value Stable IndexNew Virus PreventionRestructuringCOVID-19 PreventionAntigen Self-testGene SequencingSmart HealthcareCOVID-19 TestingFTSE Russell ConceptHuijin ConceptShareholding Increase CommitmentStocks Below Book ValuePrecision MedicinePublic Health IndexSZSE Responsibility IndexCS High-end Manufacturing IndexSME Board Innovation IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI IndexCSI 1000 IndexCCTV Governance IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexChiNext Basic IndexSZSE Component Pharmaceutical IndexSZSE Low Volatility IndexCSI All-share Pharmaceutical IndexSZSE Pharmaceutical 50 IndexSZSE 300 Equal Weight IndexChiNext Low Volatility IndexCSI 500 Equal Weight IndexSZSE Component Index Equal WeightCSI 700 IndexMid-small Cap IndexCSI 500 IndexCSI 500 IndexZhongchuang High Beta IndexZhongchuang Low Volatility IndexSmall-cap Low Volatility IndexCSI Life Sciences IndexSZSE 200 Return IndexSZSE 200 IndexZhongchuang 400 IndexESG 300 IndexZhejiang 100 IndexChina Economic Index GDPChiNext Return IndexCSI 1000 Value IndexSZSE 500 IndexChiNext Emerging IndexCSI 500 ESG IndexCS Yangtze River Delta IndexZhejiang

K-Line Chart

No K-line data available

Company NameDian Diagnostics Technology Group Co., Ltd.
Listing Date2011-07-19
Issue Price23.5RMB
Registered Capital62497.943610k RMB
Legal RepresentativeChen Haibin
Registered Address5th Floor, Building 2, No. 329 Jinpeng Street, Sandun Town, Xihu District, Hangzhou City, Zhejiang Province
IndustryMedical Services
Main BusinessProviding comprehensive medical diagnostic service solutions, with a core business of outsourcing medical diagnostic services, to various levels of healthcare institutions such as general and specialized hospitals, community health service centers (stations), township (town) health centers, physical examination centers, and disease prevention and control centers.
Company ProfileDian Diagnostics Technology Group Co., Ltd. was founded in 2001 and is an independent third-party medical diagnostic service provider with a core business of outsourcing diagnostic services. It has become an industry pioneer and advocate with its unique integrated "Service + Product" business model. It was the first to be listed in July 2011 (Stock Code: 300244), achieving a "zero breakthrough" for the listing of independent medical laboratories in China.

Stock Details

1. Key Indicators

  • Total Shares(W): 62497.94
  • Circulating A-Shares(W): 50145.91
  • Earnings Per Share(RMB): 0.0928
  • Net Assets Per Share(RMB): 10.3519
  • Operating Revenue(W RMB): 756558.67
  • Total Profit(W RMB): 27608.91
  • Net Profit Attributable to Parent(W RMB): 5670.48
  • Net Profit Growth Rate(%): -56.67
  • Weighted Return on Equity(%): 0.8700
  • Operating Cash Flow Per Share(RMB): 1.3950
  • Undistributed Profit Per Share(RMB): 6.2941
  • Capital Reserve Per Share(RMB): 2.9324

2. Main Business

The main business covers:

  • Medical diagnostic services
  • Diagnostic technology R&D
  • Diagnostic product manufacturing and sales
  • Judicial expertise
  • Health management

3. Company Basic Information

  • Company Name: Dian Diagnostics Group Co., Ltd.
  • Listing Date: 2011-07-19
  • Industry: Medical & Healthcare - Medical Services
  • Address: 5th Floor, Building 2, No. 329 Jinpeng Street, Sandun Town, Xihu District, Hangzhou City, Zhejiang Province
  • Website: www.dazd.cn
  • Company Profile: The company was established as a joint stock company on May 12, 2010, through the overall transformation of Dian Co., Ltd. The promoters include Mr. Chen Haibin, Shanghai Fosun, Tianjin SoftBank, Mr. Hu Yong, Ms. Xu Min, and Ms. Lai Cuiying. On January 20, 2010, a shareholders' meeting resolved to transform Dian Co., Ltd. into a joint stock company. The audited net assets of RMB 82,968,000 as of December 31, 2009, were converted into 36 million shares with a par value of RMB 1 per share, and the remaining RMB 46,968,000 was recorded as capital reserve. On May 5, 2010, Lixin Certified Public Accountants issued the Xinhui Shi Bao Zi (2010) No. 24084 "Capital Verification Report," confirming the capital contribution of the joint stock company. On May 12, 2010, the Hangzhou Administration for Industry and Commerce issued the "Business License" (Registration No. 330106000013053) to the company.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hangzhou Dian Holding Co., Ltd. General Legal Person 1063.64 2.12
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 1056.35 2.11
3 Southern China Securities 1000 ETF Fund 456.88 0.91
4 Abu Dhabi Investment Authority - Proprietary Account QFII 427.03 0.85
5 Yongying CSI All Share Medical Devices ETF Fund 308.75 0.62
6 Wanjia Health Industry Hybrid Securities Investment Fund Class A Fund 22.20 0.04

5. Concept Sectors

  • Infant & Child Concept
  • Belt and Road Initiative
  • Elderly Care Concept
  • Vocational Education
  • Gene Concept
  • Immunotherapy
  • Alibaba Concept
  • Artificial Intelligence
  • CXO Concept
  • Cold Chain Logistics
  • Assisted Reproduction
  • Hepatitis Concept
  • AIGC Concept
  • ChatGPT
  • Data Elements
  • Multimodal AI
  • AI Agent
  • DeepSeek
  • AI Healthcare
  • Margin Trading & Securities Lending
  • Low-Profit Stock
  • QFII Heavy Holdings
  • CCTV 50
  • ChiNext 300
  • ChiNext Blue Chips
  • ChiNext Healthcare
  • ChiNext Small Cap

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information